Skip to main content
Full access
Letter to the Editor
Published Online: 1 August 1998

Conventional Psychotropic-Induced Tremor Extinguished by Olanzapine

Publication: American Journal of Psychiatry
TO THE EDITOR: We have observed, unexpectedly, the disappearance of prominent, persistent, and troublesome fluphenazine- or haloperidol-induced coarse tremors in three patients within days of initiation of treatment with olanzapine, 10 mg/day p.o., without discontinuance of or decrement in the dose of either fluphenazine or haloperidol. Treatment with diphenhydramine, benztropine, amantadine, and propanolol—tried in cases 1 and 2 only—had provided negligible and transient tremor relief. Our intent, then, was to wean all three patients from fluphenazine or haloperidol while starting olanzapine, but we observed the following responses:
Case 1. Mr. A, a 36-year-old Caucasian man with an 18-year history of recurrent command hallucinations, suicide attempts, paranoid delusions, severe depression, and alcohol dependence, had been in remission for 1 year on a regimen of fluphenazine decanoate, 37.5 mg i.m. every 2 weeks, and nefazodone, 100 mg p.o. at bedtime. The patient experienced coarse truncal and extremity tremors. Four days after the addition of olanzapine, 10 mg/day p.o., to his regimen, his tremors had noticeably diminished; by day 7, they were no longer apparent. Without further medication adjustment, the tremors had not returned after 26 weeks.
Case 2. Ms. B, a 25-year-old African American woman with a 2-year history of recurrent paranoid ideation, violent behavior, psychotic depression, and mania, with intercurrent marijuana, heroin, and “crack” cocaine abuse, had been in remission for 1 year on a regimen of fluphenazine decanote, 25 mg i.m. every 2 weeks; fluphenazine, 7.5 mg p.o. at bedtime; and divalproex sodium, 1000 mg p.o. twice a day. She had developed coarse hand tremors that disappeared within 7 days of the addition of olanzapine, 10 mg p.o.; her tremors had not returned after 21 weeks without other medication changes.
Case 3. Ms. C, a 34-year-old African American woman with a 20-year history of recurring severe thought disorganization or mania, had been in remission for 1 year on a regimen of haloperidol, 20 mg p.o. at bedtime; lithium carbonate, 300 mg p.o. twice a day; and divalproex sodium, 750 mg p.o. twice a day. She had unsightly coarse circumoral and hand tremors, not relieved with lithium discontinuance. Her tremors disappeared 1 week after initiation of treatment with olanzapine, 10 mg/day p.o., without other medication adjustments; her tremors had not returned after 20 weeks.
Olanzapine is active against muscarinic cholinergic receptors (1), a fact that may account for the observed suppression of fluphenazine- and haloperidol-induced tremor. The patients in cases 1 and 2, however, had been treated with benztropine, an antagonist of muscarinic acetylcholine receptors, with little tremor relief, suggesting that olanzapine could suppress tremor by means other than antimuscarinic action.

Reference

1.
Bymaster FP, Rasmussen K, Calligaro DO, Nelson DL, DeLapp NW, Wong, DT, Moore, NA: In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug. J Clin Psychiatry 1997; 58(suppl 10): 28–36

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1132

History

Published online: 1 August 1998
Published in print: August 1998

Authors

Affiliations

Arthur J.L. Strauss, M.D.
Penelope W. Dralle, Ph.D.
Anthony J. Eschmann, B.C.S.W.
Richard B. Wagner, M.S.W., M.U.R.P.
New Orleans, La.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share